MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

Search

Simulations Plus Inc

Cerrado

SectorSanidad

14.27 1.64

Resumen

Variación precio

24h

Actual

Mínimo

14.21

Máximo

14.4

Métricas clave

By Trading Economics

Ingresos

3.9M

4.5M

Ventas

5.9M

24M

BPA

0.35

Rentabilidad por dividendo

0.48

Margen de beneficios

18.669

Empleados

212

EBITDA

4.9M

7.2M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+63.54% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.38%

Próximas Ganancias

13 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

11M

262M

Apertura anterior

12.63

Cierre anterior

14.27

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

135 / 348 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

19 abr 2026, 23:48 UTC

Noticias de Eventos Importantes

Crude Oil, Refined Product Prices Moving Higher Amid Renewed Tensions in Strait of Hormuz -- OPIS

19 abr 2026, 23:36 UTC

Noticias de Eventos Importantes

NAB Raises Provisions as Australian Banks Face Iran Risks -- Update

19 abr 2026, 22:47 UTC

Noticias de Eventos Importantes

National Australia Bank Adds $215 Million in Iran-Driven Credit Provisions

19 abr 2026, 21:14 UTC

Noticias de Eventos Importantes

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

19 abr 2026, 21:14 UTC

Noticias de Eventos Importantes

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

19 abr 2026, 23:49 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold, Silver Decline Amid Renewed Inflation Concerns -- Market Talk

19 abr 2026, 23:46 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

19 abr 2026, 23:38 UTC

Noticias de Eventos Importantes

U.A.E. Asks U.S. About a Wartime Financial Lifeline -- Update

19 abr 2026, 23:36 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Oil Climbs on Renewed Tensions Over Strait of Hormuz -- Market Talk

19 abr 2026, 23:12 UTC

Noticias de Eventos Importantes

Spot Gold Falls 1.2%, Spot Silver Drops 1.6% on Renewed Middle East Tensions

19 abr 2026, 23:10 UTC

Noticias de Eventos Importantes

Front-Month Brent Crude Oil Futures Rise 5.8% to $95.64 per Barrel

19 abr 2026, 23:09 UTC

Noticias de Eventos Importantes

Front-Month WTI Crude Oil Futures Climb 7.2% to $89.86 per Barrel

19 abr 2026, 23:08 UTC

Noticias de Eventos Importantes

Front-Month Crude Oil Futures Climb on Renewed Tensions Over Strait of Hormuz

19 abr 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Eli Lilly Nears Deal for Cancer Biotech -- WSJ

19 abr 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Announcement Could Come As Soon As Monday, Sources Say -- WSJ

19 abr 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Deal Expected to Be Worth Over $2B Plus Additional Milestones, Sources Say -- WSJ

19 abr 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Eli Lilly Nears Deal for Kelonia Therapeutics, Sources Say -- WSJ

19 abr 2026, 20:03 UTC

Noticias de Eventos Importantes

U.A.E. Central Bank Governor Khaled Mohamed Balama Raised Swap Idea With Treasury Secretary Scott Bessent in Washington -- WSJ

19 abr 2026, 20:03 UTC

Noticias de Eventos Importantes

Emiratis Portrayed Swap Proposal as Precautionary and Preliminary in Case Iran War Drags On -- WSJ

19 abr 2026, 20:03 UTC

Noticias de Eventos Importantes

The U.A.E. Has Opened Talks with U.S. for Currency Swap -- WSJ

19 abr 2026, 20:03 UTC

Noticias de Eventos Importantes

U.A.E. Asks U.S. for a Wartime Financial Lifeline -- WSJ

18 abr 2026, 01:00 UTC

Noticias de Eventos Importantes

As Economic Pressures Mount, Will Iran or the U.S. Blink First? -- WSJ

17 abr 2026, 22:58 UTC

Ganancias

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 abr 2026, 21:32 UTC

Charlas de Mercado

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 abr 2026, 21:22 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 abr 2026, 21:22 UTC

Charlas de Mercado

Moody's Downgrades Belgium to A1 -- Market Talk

17 abr 2026, 20:52 UTC

Ganancias

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 abr 2026, 20:50 UTC

Charlas de Mercado
Ganancias
Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

17 abr 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

17 abr 2026, 20:29 UTC

Ganancias

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

63.54% repunte

Estimación a 12 Meses

Media 23.5 USD  63.54%

Máximo 31 USD

Mínimo 16 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

135 / 348 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat